Dr. Shubhra Jain is an investor at Cota Capital where she is responsible for sourcing, executing and analyzing healthcare investments. Cota Capital is a stage agnostic fund in San Francisco investing in Healthcare, Tech and Fintech. Prior to Cota, Shubhra was Associate Director of Commercial Strategy and Corporate Development at Natera where she focused on biopharma partnerships, acquisitions, market research and competitive positioning. Prior to Natera, she led Product management for Acute care suite of products at Pieces Technologies where she led product development and launch of SaaS risk surveillance and prediction solutions for clinical outcomes and published peer-reviewed research on the subject. Dr. Jain has served as a consultant and an advisor to several health tech startups and Fortune 500 companies.
Dr. Jain is a Primary Care Physician by background, has her Masters in Engineering from Stanford with a major in Biodesign and her MBA from the Wharton School of Business.